Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata can be transferred through stem cell transplants from affected siblings.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

A genetic marker linked to a type of hair loss was found in most patients studied.

Two siblings both had a rare case of alopecia areata at the same time.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.